Literature DB >> 6906946

Eradication of epidemic methicillin-gentamicin-resistant staphylococcus aureus in an intensive care nursery.

L M Dunkle, S H Naqvi, R McCallum, J P Lofgren.   

Abstract

A methicillin-resistant strain of Staphylococcus aureus (phage type 47,54,75,83A) became epidemic in our 50 bed level III nursery, with a colonization rate of 70 percent and an infection rate of more than 25 percent. This prevalence and the appearance of gentamicin resistance necessitated epidemic control measures. Standard measures included separate housing for infants in whom colonization had occurred and infants in whom it had not, low nurse to patient ratios, and cohorting of all personnel. Use of all antibiotics was curtailed by the requirement of infectious disease consultation. Gentamicin was available only on order of the Director. The colonization rate fell from 55 percent to 25.4 percent, the first-week colonization rate from 31 percent to 0 percent, and the infection rate from 29.3 percent to 15.9 percent over eight weeks. The mean duration of antibiotic therapy decreased from 12.21 to 9.05 days per treated patient; however, the frequency of gentamicin usage and the proportion of gentamicin resistance were unchanged. Nurse to patient ratios were modified to allow increased admissions, but cohorting was continued for 12 weeks until all infants in whom colonization had occurred were discharged. With the elimination of the reservoir, no further colonization occurred and antibiotic resistance did not reappear. Standard infection control measures can eliminate epidemics of multiple antibiotic-resistant Staph. aureus, and control of antibiotic usage may present re-emergence of resistant strains.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6906946     DOI: 10.1016/0002-9343(81)90787-7

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  9 in total

1.  The epidemiology of antibiotic resistance in hospitals: paradoxes and prescriptions.

Authors:  M Lipsitch; C T Bergstrom; B R Levin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

2.  Persistent colonization and the spread of antibiotic resistance in nosocomial pathogens: resistance is a regional problem.

Authors:  David L Smith; Jonathan Dushoff; Eli N Perencevich; Anthony D Harris; Simon A Levin
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-25       Impact factor: 11.205

3.  Outbreaks of infection with methicillin-resistant Staphylococcus aureus on neonatal and burns units of a new hospital.

Authors:  M Farrington; J Ling; T Ling; G L French
Journal:  Epidemiol Infect       Date:  1990-10       Impact factor: 2.451

4.  Methicillin-resistant Staphylococcus aureus: associated morbidity and effectiveness of control measures.

Authors:  M R Law; O N Gill; A Turner
Journal:  Epidemiol Infect       Date:  1988-10       Impact factor: 2.451

5.  Methicillin resistant Staphylococcus aureus in milk.

Authors:  Y A Parks; M F Noy; M A Aukett; C A Webb
Journal:  Arch Dis Child       Date:  1987-01       Impact factor: 3.791

6.  Ciprofloxacin-resistant methicillin-resistant Staphylococcus aureus in New York health care facilities, 1988. The New York MRSA Study Group.

Authors:  L D Budnick; S Schaefler
Journal:  Am J Public Health       Date:  1990-07       Impact factor: 9.308

7.  Antimicrobial use and antimicrobial resistance: a population perspective.

Authors:  Marc Lipsitch; Matthew H Samore
Journal:  Emerg Infect Dis       Date:  2002-04       Impact factor: 6.883

8.  Latex agglutination-negative methicillin-resistant Staphylococcus aureus recovered from neonates: epidemiologic features and comparison of typing methods.

Authors:  A R Wanger; S L Morris; C Ericsson; K V Singh; M T LaRocco
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

Review 9.  "Cloud" health-care workers.

Authors:  R J Sherertz; S Bassetti; B Bassetti-Wyss
Journal:  Emerg Infect Dis       Date:  2001 Mar-Apr       Impact factor: 6.883

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.